Latarcin 2a
General Information
DCTPep ID DCTPep00433
Peptide Name Latarcin 2a
Sequence GLFGKLIKKFGRKAISYAVKKARGKH
Sequence Length 26
UniProt ID Q1ELU1
PubChem CID Not available
Origin Central Asian spider, Lachesana tarabaevi
Type Native peptide
Classification
ACP Tumor active peptide
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
K562 | Blast phase chronic myelogenous leukemia, BCR-ABL1 positive; Chronic myeloid leukemia | EC50=3.3μM | LDH leakage assay | Not available | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID 2G9P
Predicted Structure DCTPep00433
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C136H229N41O29
Absent amino acids CDEMNPQTW
Theoretical pI 11.33
Acidic residues 0
Basic residues 10
Polar residues 6
Molecular weight (Average) 2902.57
Molecular weight (Monoisotopic) 2900.77
Common amino acids K
Net charge 10
Instability index (II) 1.29
Aliphatic index 82.69
Grand average of hydropathicity (GRAVY) -0.438
Half Life
30 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 1490
Abs 0.1% (=1 g/l) 0.513
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 20887768
Title Haemolytic and cytotoxic action of latarcin Ltc2a
Doi 10.1016/j.biochi.2010.09.016
Year 2011
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available